CellaVision Net Income vs. Market Capitalization

Please note, there is a significant difference between CellaVision's value and its price as these two are different measures arrived at by different means. Investors typically determine if CellaVision is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CellaVision's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

CellaVision AB Market Capitalization vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining CellaVision's current stock value. Our valuation model uses many indicators to compare CellaVision value to that of its competitors to determine the firm's financial worth.
CellaVision AB is number one stock in net income category among its peers. It also is number one stock in market capitalization category among its peers creating about  32.92  of Market Capitalization per Net Income. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CellaVision's earnings, one of the primary drivers of an investment's value.

CellaVision Market Capitalization vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

CellaVision

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
158.3 M
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

CellaVision

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
5.21 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

CellaVision Market Capitalization vs Competition

CellaVision AB is number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is currently estimated at about 38.51 Billion. CellaVision retains roughly 5.21 Billion in market capitalization claiming about 14% of equities under Health Care industry.
Capitalization  Workforce  Total debt  Valuation  Revenue

CellaVision Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in CellaVision, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CellaVision will eventually generate negative long term returns. The profitability progress is the general direction of CellaVision's change in net profit over the period of time. It can combine multiple indicators of CellaVision, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.

CellaVision Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on CellaVision. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CellaVision position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CellaVision's important profitability drivers and their relationship over time.

CellaVision Earnings per Share Projection vs Actual

Use CellaVision in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CellaVision position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CellaVision will appreciate offsetting losses from the drop in the long position's value.

CellaVision Pair Trading

CellaVision AB Pair Trading Analysis

The ability to find closely correlated positions to CellaVision could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CellaVision when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CellaVision - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CellaVision AB to buy it.
The correlation of CellaVision is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CellaVision moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CellaVision AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CellaVision can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your CellaVision position

In addition to having CellaVision in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ESG Investing Thematic Idea Now

ESG Investing
ESG Investing Theme
Sustainable investments that promote the conservation of the natural world, social resposibility, freindly employees policies and strong governance. The ESG Investing theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ESG Investing Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CellaVision Stock Analysis

When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.